Bailey Regan L, Fulgoni Victor L, Taylor Christine L, Pfeiffer Christine M, Thuppal Sowmyanarayanan V, McCabe George P, Yetley Elizabeth A
Departments of Nutrition Science and
Office of Dietary Supplements, NIH, Bethesda, MD.
Am J Clin Nutr. 2017 Jun;105(6):1336-1343. doi: 10.3945/ajcn.116.148775. Epub 2017 Apr 26.
Public health concerns with regard to both low and high folate status exist in the United States. Recent publications have questioned the utility of self-reported dietary intake data in research and monitoring. The purpose of this analysis was to examine the relation between self-reported folate intakes and folate status biomarkers and to evaluate their usefulness for several types of applications. We examined usual dietary intakes of folate by using the National Cancer Institute method to adjust two 24-h dietary recalls (including dietary supplements) for within-person variation and then compared these intakes with serum and red blood cell (RBC) folate among 4878 men and nonpregnant, nonlactating women aged ≥19 y in NHANES 2011-2012, a nationally representative, cross-sectional survey, with respect to consistency across prevalence estimates and rank order comparisons. There was a very low prevalence (<1%) of folate deficiency when serum (<7 nmol/L) and RBC (<305 nmol/L) folate were considered, whereas a higher proportion of the population reported inadequate total dietary folate intakes (6%). Similar patterns of change occurred between intakes and biomarkers of folate status when distributions were examined (i.e., dose response), particularly when diet was expressed in μg. Intakes greater than the Tolerable Upper Intake Level greatly increased the odds of having high serum folate (OR: 17.6; 95% CI: 5.5, 56.0). When assessing folate status in the United States, where fortification and supplement use are common, similar patterns in the distributions of diet and biomarkers suggest that these 2 types of status indicators reflect the same underlying folate status; however, the higher prevalence estimates for inadequate intakes compared with biomarkers suggest, among other factors, a systematic underestimation bias in intake data. Caution is needed in the use of dietary folate data to estimate the prevalence of inadequacy among population groups. The use of dietary data for rank order comparisons or to estimate the potential for dietary excess is likely more reliable.
在美国,叶酸水平过低和过高都引发了公共卫生方面的担忧。近期的出版物对研究和监测中自我报告的饮食摄入数据的效用提出了质疑。本分析的目的是研究自我报告的叶酸摄入量与叶酸状态生物标志物之间的关系,并评估它们在几种应用类型中的有用性。我们采用美国国立癌症研究所的方法,对两份24小时饮食回忆(包括膳食补充剂)进行个体内变异调整,以检查叶酸的通常饮食摄入量,然后将这些摄入量与2011 - 2012年美国国家健康与营养检查调查(NHANES)中4878名年龄≥19岁的男性以及非孕、非哺乳期女性的血清和红细胞(RBC)叶酸进行比较。NHANES是一项具有全国代表性的横断面调查,涉及患病率估计的一致性和排序比较。当考虑血清叶酸(<7 nmol/L)和红细胞叶酸(<305 nmol/L)时,叶酸缺乏的患病率非常低(<1%),而报告膳食总叶酸摄入量不足的人群比例较高(6%)。在检查分布情况时(即剂量反应),叶酸摄入量与叶酸状态生物标志物之间出现了相似的变化模式,特别是当饮食以微克表示时。摄入量超过可耐受最高摄入量会大大增加血清叶酸水平过高的几率(比值比:17.6;95%置信区间:5.5,56.0)。在美国,强化食品和补充剂的使用很普遍,在评估叶酸状态时,饮食和生物标志物分布的相似模式表明这两种状态指标反映了相同的潜在叶酸状态;然而,与生物标志物相比,摄入量不足的患病率估计较高,这表明除其他因素外,摄入数据存在系统性低估偏差。在使用膳食叶酸数据估计人群中不足患病率时需要谨慎。使用膳食数据进行排序比较或估计膳食过量的可能性可能更可靠。